Nakai, Michael E.
Denham, Joshua
Prestes, Priscilla R.
Eikelis, Nina
Lambert, Elisabeth A.
Straznicky, Nora E.
Schlaich, Markus P.
Esler, Murray D.
O’Brien, Brendan J.
Charchar, Fadi J.
Lambert, Gavin W.
Marques, Francine Z.
Funding for this research was provided by:
National Health and Medical Research Council
National Heart Foundation of Australia
Article History
Received: 6 March 2020
Accepted: 29 December 2020
First Online: 18 February 2021
Competing interests
: MPS has received research support from Medtronic, Abbott, Novartis, Servier, Pfizer, and Boehringer-Ingelheim. GWL has acted as a consultant for Medtronic. FZM is supported by a National Heart Foundation Future Leader Fellowship, a National Health and Medical Research Council Project Grant and a National Heart Foundation Vanguard Grant. GWL, NE and EAL are supported by Swinburne Research, Swinburne University of technology. MPS is supported by an NHMRC Research Fellowship. All other authors declare no competing interests. Data used in this manuscript is available upon request.